Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
05/2005
05/25/2005EP1532987A1 Agents for gene therapeutic for cerebrovascular disorders
05/25/2005EP1532985A1 Process for producing sustained-release composition
05/25/2005EP1532976A2 Compositions comprising organic disulfides, cysteine sulfoxides, sulfones, sulfoximines or other sulfur containing substances and their use in therapy in combination with radiation
05/25/2005EP1532446A2 G-protein coupled receptor ligands and methods
05/25/2005EP1532434A1 Methods and compositions for inhibition of multi-drug resistance by hyaluronan oligomers
05/25/2005EP1532280A2 Endosymbiotic gammaproteobacterium identified in ecteinascidia turbinata
05/25/2005EP1532258A1 Treatment of vascular dysfunction and alzheimer's disease
05/25/2005EP1532254A2 Helper virus-free herpesvirus amplicon particles and uses thereof
05/25/2005EP1532251A1 Human acid sensing ion channel 2b (hasic2b), process for producing the same, and its use
05/25/2005EP1532249A2 Rnai probes targeting cancer-related proteins
05/25/2005EP1532248A1 Modified small interfering rna molecules and methods of use
05/25/2005EP1532246A2 Genetic suppression and replacement
05/25/2005EP1532242A2 Methods for preparing purified prostaglandin e synthase
05/25/2005EP1532241A2 Rationally designed polysaccharide lyases derived from chondroitinase b
05/25/2005EP1532238A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
05/25/2005EP1532176A2 Cd200-receptor mediated modulation of bone development
05/25/2005EP1532171A1 Protein tyrosine phosphatase inhibitors
05/25/2005EP1532170A2 Beta-sheet breaking peptides
05/25/2005EP1532164A1 Template-fixed peptidomimetics with antibacterial activity
05/25/2005EP1532163A2 Androgen receptor coregulators
05/25/2005EP1532160A2 Antisense modulation of insulin-like growth factor 2 expression
05/25/2005EP1532159A2 Scaffolded maleimide clusters for multivalent peptide assembly
05/25/2005EP1531906A1 Novel screens to identify agents that modulate retinal blood vessel function and pericyte function and diagnostic and therapeutic application therefor
05/25/2005EP1531905A1 Metallothionein based neuronal therapeutic and therapeutic methods
05/25/2005EP1531865A2 Methods and compositions for the repair and/or regeneration of damaged myocardium
05/25/2005EP1531863A2 Antibody-avidin fusion proteins as cytotoxic drugs
05/25/2005EP1531859A1 Compositions and methods for transepithelial molecular transport
05/25/2005EP1531857A1 Metalloproteinase inhibitors
05/25/2005EP1531856A1 Method for treatment of indwelling catheter occlusion using fibrinolytic metalloproteinases
05/25/2005EP1531855A2 Treatment of bone disorders with skeletal anabolic drugs
05/25/2005EP1531853A1 Synergistic combination of silk proteins
05/25/2005EP1531852A1 Caspase 9 activation and uses therefor
05/25/2005EP1531851A2 Covalent conjugates between artemisinin-related endoperoxides and iron-carrying proteins and methods of use
05/25/2005EP1531850A2 Use of il-21 in cancer and other therapeutic applications
05/25/2005EP1531849A2 System and method for inhibiting cellular proliferation with tachykinins
05/25/2005EP1531848A2 Gene differentially expressed in breast and bladder cancer and encoded polypeptides
05/25/2005EP1531847A2 Pharmaceutical formulation
05/25/2005EP1531846A2 Conjugates of ligand, linker and cytotoxic agent and related compositions and methods of use
05/25/2005EP1531845A2 Inhibitors for use in hemostasis
05/25/2005EP1531843A1 Method for treating cervical cancer
05/25/2005EP1531842A2 Regulation of cell growth by muc1
05/25/2005EP1531836A2 Polypeptide cleavage process
05/25/2005EP1531834A1 Antisense compounds, methods and compositions for treating ngal-related inflammatory disorders
05/25/2005EP1531833A1 Antisense compounds, methods and compositions for treating mmp-12 related inflammatory disorders
05/25/2005EP1531825A2 Use of apoptosis inducing agents in the preparation of a medicament for the treatment of liver diseases
05/25/2005EP1531818A1 Topical treatment of skin diseases
05/25/2005EP1531808A1 Peroxynitrite rearrangement catalysts used for the treatment or prophylaxis of diseases caused by peroxynitrite-mediated reactions
05/25/2005EP1531804A1 Method of inhibiting angiogenesis
05/25/2005EP1531803A1 Method of inhibiting prostate cancer cell proliferation
05/25/2005EP1531797A1 Biodegradable block copolymeric compositions for drug delivery
05/25/2005EP1531791A2 Prevention and reduction of blood loss
05/25/2005EP1531716A2 Methods for using adamts-12, an integrin and metalloprotease with thrombospondin motifs
05/25/2005EP1531676A2 Compositions and methods for liver growth and liver protection
05/25/2005EP1363654A4 Fab i and inhibition of apicomplexan parasites
05/25/2005EP1322286B1 Polymeric delivery formulations of leuprolide with improved efficacy
05/25/2005EP1279039A4 Diagnostic assay and method of treatment involving macrophage inhibitory cytokine -1 (mic-1)
05/25/2005EP1214059B1 Surface modified particulate compositions of biologically active substances
05/25/2005EP1165058B1 Azalide antibiotics for the topical treatment or prevention of ocular infections
05/25/2005EP1163335B1 MATERIALS AND METHODS RELATING TO MODULATION OF p66 EXPRESSION
05/25/2005EP1162992B1 Cyanovirin conjugates, matrix-anchored cyanovirin and anti-cyanovirin antibody, and related compositions and methods of use
05/25/2005EP1115434B1 Adhesive protein foam for surgical and/or therapeutic uses
05/25/2005EP1113813B1 In-vitro method of using zot or zonulin to inhibit lymphocyte proliferation in an antigen-specific manner
05/25/2005EP1097164A4 Processes for coupling amino acids using bis-(trichloromethyl) carbonate
05/25/2005EP1023320B1 PEPTIDES DERIVED FROM THE env GENE OF THE FELINE IMMUNODEFICIENCY VIRUS AND THEIR APPLICATIONS
05/25/2005EP1017421B1 Use of adenoviral vectors expressing VEGF or PDGF FOR HEALING TISSUE DEFECTS AND INDUCING HYPERVASCULARITY IN MAMMALIAN TISSUE
05/25/2005EP0994903B1 Methods and compositions for galactosylated glycoproteins
05/25/2005EP0907370B1 Hla-a2.1 binding peptides and their uses
05/25/2005EP0888541B1 Cryptic peptides and method for their identification
05/25/2005EP0880362B1 Compositions comprising a cyclooxygenase-2 inhibitor and a leukotriene b 4 receptor antagonist
05/25/2005EP0871702B1 Cytokine designated lerk-7
05/25/2005EP0862461B1 Methods of treating established colitis using antibodies against il-12
05/25/2005EP0813419B1 Modulators of regulatory proteins
05/25/2005EP0813416B1 Reduction of infarct volume using citicoline
05/25/2005EP0755451B1 Materials and methods for management of hyperacute rejection in human xenotransplantation
05/25/2005EP0733060B1 Metal chelators
05/25/2005EP0479866B2 Pestivirus nucleotide sequences and polypeptides, in particular from hog cholera virus
05/25/2005DE10392821T5 Synteseverfahrens für Alanylglutamin Synteseverfahrens for alanylglutamine
05/25/2005CN1620655A System and method for controlling user interface attribute by data
05/25/2005CN1620510A Cytokine protein family
05/25/2005CN1620505A Pim-3 kinase as a target for type 2 diabetes mellitus
05/25/2005CN1620500A Corona-virus-like particles comprising functionally deleted genomes
05/25/2005CN1620467A Secreted protein
05/25/2005CN1620466A Cystine-knot fold protein
05/25/2005CN1620464A Peptides for the treatment of cancer associated with the human papilloma virus (hpv) and other epithelial tumors
05/25/2005CN1620314A Gas micro-liposome compound
05/25/2005CN1620310A Chimeric infectious DNA clones, chimeric porcine circoviruses and uses thereof
05/25/2005CN1620309A Novel pharmaceutical composition of interferon gamma or pirfenidone with molecular diagnostics for the improved treatment of interstitial lung diseases
05/25/2005CN1620308A Use of a pharmaceutical composition containing epidermal growth factor (EGF) for diabetic foot amputation prevention
05/25/2005CN1620307A Anti-HIV agent
05/25/2005CN1620306A Systems and methods for treating patients with collagen-rich material extracted from adipose tissue
05/25/2005CN1620304A Prevention and treatment of oxidative stress disorders by glutathione and phase IIdetoxification enzymes
05/25/2005CN1620283A Dispersions for formulating slightly or poorly soluble active ingredients
05/25/2005CN1620255A Protein-containing foodstuff comprising a coss-linking enzyme and a hydrocolloid
05/25/2005CN1620251A Cultured and encapsulated pancreatic stem cells
05/25/2005CN1620174A Cellular telecommunication system
05/25/2005CN1619312A Specific markers for metabolic syndrome
05/25/2005CN1618969A Mammalian sytokine-like polypeptide-10
05/25/2005CN1618958A Human cholesteryl ester synthetase-2c and its coding sequence
05/25/2005CN1618957A Human cholesteryl ester synthetase-2b and its coding sequence
05/25/2005CN1618814A Method of diagnosing and treating heritage spasm paraplegia using NIPAl gene mutation hot point
1 ... 1439 1440 1441 1442 1443 1444 1445 1446 1447 1448 1449 1450 1451 1452 1453 1454 1455 1456 1457 1458 1459 ... 3163